About Predictably Human

Predictably Human has developed the NoMore platform, which integrates precision drug delivery with a mobile app that utilizes cloud-based AI and data analytics for personalized treatment of chronic diseases and addiction, starting with nicotine dependence. This platform addresses the ineffectiveness of current mental health and substance use disorder treatments by providing coordinated, adaptive therapies tailored to individual patient needs.

```xml <problem> Current treatments for mental health and substance use disorders often prove ineffective due to their failure to address individual patient needs in a coordinated and adaptive manner. Existing approaches lack the integration of physiological and psychological care, resulting in suboptimal outcomes. </problem> <solution> Predictably Human's NoMore platform integrates precision drug delivery with a mobile app, leveraging cloud-based AI and data analytics to provide personalized treatment for chronic diseases and addiction, starting with nicotine dependence. The platform delivers coordinated, adaptive therapies tailored to individual patient needs. By combining these technologies, NoMore aims to create an ecosystem of digital products and services that improve the lives of patients with mental health, addiction, and other complex disorders. The system integrates physiological and psychological care to provide a more sophisticated solution. </solution> <features> - Precision drug delivery system for controlled medication administration. - Companion mobile app for patient engagement and data collection. - Cloud-based AI and data analytics for personalized treatment plans. - Adaptive therapy adjustments based on real-time patient data. - Integration of physiological and psychological care components. </features> <target_audience> The primary target audience includes individuals suffering from chronic diseases and addiction, particularly nicotine dependence, as well as healthcare providers seeking more effective and personalized treatment options. </target_audience> ```

What does Predictably Human do?

Where is Predictably Human located?

Predictably Human is based in Boston, United States.

When was Predictably Human founded?

Predictably Human was founded in 2022.

How much funding has Predictably Human raised?

Predictably Human has raised 7900000.

Location

Boston, United States

Founded

2022

Funding

7900000

Employees

7 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Predictably Human

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

predictablyhuman.com 300+

Founded 2022 – Boston, United States

Funding

Estimated Funding

$5M+

Team (5+)

No team information available.

Company Description

Problem

Current treatments for mental health and substance use disorders often prove ineffective due to their failure to address individual patient needs in a coordinated and adaptive manner. Existing approaches lack the integration of physiological and psychological care, resulting in suboptimal outcomes.

Solution

Predictably Human's NoMore platform integrates precision drug delivery with a mobile app, leveraging cloud-based AI and data analytics to provide personalized treatment for chronic diseases and addiction, starting with nicotine dependence. The platform delivers coordinated, adaptive therapies tailored to individual patient needs. By combining these technologies, NoMore aims to create an ecosystem of digital products and services that improve the lives of patients with mental health, addiction, and other complex disorders. The system integrates physiological and psychological care to provide a more sophisticated solution.

Features

Precision drug delivery system for controlled medication administration.

Companion mobile app for patient engagement and data collection.

Cloud-based AI and data analytics for personalized treatment plans.

Adaptive therapy adjustments based on real-time patient data.

Integration of physiological and psychological care components.

Target Audience

The primary target audience includes individuals suffering from chronic diseases and addiction, particularly nicotine dependence, as well as healthcare providers seeking more effective and personalized treatment options.